Renaissance Technologies LLC 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 3:57 pm Purchase | 2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Renaissance Technologies LLC | 26,631 0.530% | 26,631 (New Position) | Filing |